当前位置:首页 / 健脾补督汤联合隔附子饼灸对溃疡性结肠炎患者中医证候积分及炎症介质水平的影响
专栏:民族医药研究 | 更新时间:2025-08-04
|
健脾补督汤联合隔附子饼灸对溃疡性结肠炎患者中医证候积分及炎症介质水平的影响
Effect of spleen-fortifying and governor vessel-tonifying decoction combined with moxibustion on aconite cake on TCM syndrome scores and inflammatory mediator levels in patients with ulcerative colitis

内科 页码:294-299

作者机构:河南省驻马店市中医院,驻马店市 463800

DOI:10.16121/j.cnki.cn45-1347/r.2025.03.13

  • 中文简介
  • 英文简介
  • 参考文献

目的 分析健脾补督汤联合隔附子饼灸治疗溃疡性结肠炎的临床疗效。方法 选取96例溃疡性结肠炎患者,将其随机分为对照组和研究组,各48例。对照组单用隔附子饼灸治疗,研究组在对照组的基础上加用健脾补督汤治疗。比较两组治疗前后中医证候积分、炎症介质水平、肠黏膜屏障功能指标、临床评分(Geboes指数、肠镜下黏膜表现评分),以及疗效。结果 治疗前,两组腹泻、黏液脓血便、里急后重、肛门灼热、小便短赤的中医证候积分差异均无统计学意义(均P>0.05);治疗12周后,两组上述各项的中医证候积分均降低,且研究组上述各项的中医证候积分均低于对照组(均P<0.05)。治疗前,两组血清肿瘤坏死因子(TNF)-α、白细胞介素(IL)-6、IL-10水平差异均无统计学意义(均P>0.05);治疗12周后,两组血清TNF-α、IL-6水平均降低,血清IL-10水平均升高(均P<0.05);研究组血清TNF-α、IL-6水平均低于对照组,血清IL-10水平高于对照组(均P<0.05)。治疗前,两组血清二胺氧化酶(DAO)、D-乳酸(D-LA)水平差异均无统计学意义(均P>0.05);治疗12周后,两组血清DAO、D-LA水平均降低,且研究组血清DAO、D-LA水平均低于对照组(均P<0.05)。治疗前,两组Geboes指数、肠镜下黏膜表现评分差异均无统计学意义(均P>0.05);治疗12周后,两组Geboes指数、肠镜下黏膜表现评分均降低,且研究组Geboes指数、肠镜下黏膜表现评分均低于对照组(均P<0.05)。研究组临床总有效率(95.83%)高于对照组(81.25%)(P<0.05)。结论 健脾补督汤联合隔附子饼灸治疗溃疡性结肠炎的疗效确切,可显著地改善中医证候,其机制可能与改善肠道免疫微环境、实现促炎-抗炎因子动态平衡、恢复肠道黏膜屏障功能有关。

Objective To analyze the clinical efficacy of spleen-fortifying and governor vessel-tonifying decoction combined with moxibustion on aconite cake in the treatment of ulcerative colitis. Methods A total of 96 patients with ulcerative colitis were selected and randomly divided into a control group or a study group, with 48 cases in each group. The control group was treated with moxibustion on aconite cake alone, based on which the study group was additionally treated with spleen-fortifying and governor vessel-tonifying decoction. The Traditional Chinese Medicine (TCM) syndrome scores, levels of inflammatory mediators, indicators of intestinal mucosal barrier function, and clinical scores (Geboes index, endoscopic mucosal performance score) before and after treatment, as well as therapeutic efficacy, were compared between the two groups. Results Before treatment, there was no statistically significant difference in the TCM syndrome scores of diarrhea, mucous purulent bloody stool, tenesmus, anal burning, or short red urine between the two groups (all P>0.05); after 12 weeks of treatment, the above TCM syndrome scores in both groups decreased, and the above TCM syndrome scores in the study group were lower than those in the control group (all P<0.05). Before treatment, there was no statistically significant difference in the serum levels of tumor necrosis factor (TNF)-α, interleukin (IL)-6, or IL-10 between the two groups (all P>0.05). After 12 weeks of treatment, the serum levels of TNF-α and IL-6 in both groups decreased, while the serum level of IL-10 increased (all P<0.05); the serum levels of TNF-α and IL-6 in the study group were lower than those in the control group, and the serum level of IL-10 in the study group was higher than that in the control group (all P<0.05). Before treatment, there was no statistically significant difference in the serum levels of diamine oxidase (DAO) or D-lactic acid (D-LA) between the two groups (all P>0.05); after 12 weeks of treatment, the serum levels of DAO and D-LA in both groups decreased, and the serum levels of DAO and D-LA in the study group were lower than those in the control group (all P<0.05). Before treatment, there was no statistically significant difference in the Geboes index or endoscopic mucosal performance score between the two groups (all P>0.05); after 12 weeks of treatment, the Geboes indexes and endoscopic mucosal performance scores in both groups decreased, and the Geboes index and endoscopic mucosal performance score in the study group were lower than those in the control group (all P<0.05). The total clinical effective rate of the study group (95.83%) was higher than that of the control group (81.25%) (P<0.05). Conclusion The combined therapy of spleen-fortifying and governor vessel-tonifying decoction and moxibustion on aconite cake demonstrates significant clinical efficacy in ulcerative colitis, markedly improving TCM syndrome manifestations. The therapeutic mechanism may involve modulation of the intestinal immunologic niche, rebalancing pro- and anti-inflammatory cytokine networks, and restoration of intestinal mucosal barrier integrity.

105

浏览量

5

下载量

0

CSCD

工具集